Cancer patients treated in Victoria will benefit from more affordable access to molecular tumour profiling, following a new collaboration between the Australian Genomic Cancer Medicine [...]
The MPCCC has reviewed and enhanced its executive team and in coming weeks will form a new advisory committee to ensure both regional and state-wide [...]
As we reach the end of 2019, we reflect on many fine achievements across our partner organisations and close the year with two sentiments in mind: gratitude and [...]
Patients at Monash Health’s cancer clinic in Berwick are the first to participate in an MPCCC-funded project piloting the real-time collection of patient-reported outcome measures [...]
Monash Health, in collaboration with the Cancer Council Victoria and the Southern Melbourne Integrated Cancer Service, held a focus group on 18 November 2019 for [...]
A next-generation sequencing instrument, the NovaSeq6000, will build genomic research capacity for MPCCC partners and increase the speed and affordability of comprehensive tumour genome profiling [...]
MPCCC is set to introduce next generation sequencing (NGS)-based tumour genomic profiling to melanoma multi-disciplinary meetings (MDM’s). The pilot program is co-ordinated by the MPCCC’s [...]
MPCCC’s pilot study of a collaborative care model for cancer-related depression is feasible and could be readily implemented statewide to benefit all Victorian cancer patients, [...]
A non-invasive blood test could help doctors to diagnose cancer and monitor patient responses to treatment, based on the outcomes of MPCCC research project, The [...]
Latrobe Regional Hospital (LRH) is the first health service in Gippsland to open an oncology clinical trial, owing to the MPCCC’s Monash-Gippsland Tele-trials (MGTT) project [...]
